Dong Zhou Liu
Chief Tech/Sci/R&D Officer at HUADONG MEDICINE CO., LTD
Network origin in Dong Zhou Liu first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 16 | |
| Public Company | Pharmaceuticals: Major | 14 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Dong Zhou Liu via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd.
 Hangzhou Zhongmeihuadong Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. engages in pharmaceutical research and development, manufacturing and sales, pharmaceutical modern logistics, health industry, and medical manufacturing and sales of beauty product. It offers Chinese patent drug, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs, antibiotic drugs, medical cosmetology, and scientific research equipment. The company was founded on December 31, 1992 and is headquartered in Hangzhou, China. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer Director/Board Member | |
| dievini Verwaltungs GmbH | Chief Executive Officer Corporate Officer/Principal Chief Executive Officer Chief Executive Officer | ||
| AC IMMUNE SA | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Molecular Health, Inc.
 Molecular Health, Inc. Packaged SoftwareTechnology Services Molecular Health, Inc. operates as a cloud-based healthcare decision support technology to enable evidence-based treatment decisions. The company was founded in 2004 and is headquartered in Boston, MA. | Packaged Software | Chairman Director/Board Member Director/Board Member | |
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Molecular Health GmbH
 Molecular Health GmbH Miscellaneous Commercial ServicesCommercial Services Part of Posbelduf Biotech AG, Molecular Health GmbH is a German management consulting company. The company is based in Heidelberg, Germany. The company was founded in 2004 by Friedrich von Bohlen und Halbach. Friedrich von Bohlen und Halbach has been the CEO since 2004. | Miscellaneous Commercial Services | Chief Executive Officer Chairman Director/Board Member | |
Grand Pharma (China) Co., Ltd.
 Grand Pharma (China) Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Grand Pharmaceutical Group Ltd., Grand Pharma (China) Co., Ltd. is a Chinese pharmaceutical company that manufactures pharmaceutical products. The company is based in Wuhan, China. The company was founded in 1939. The CEO is Wei Kun Tang. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
dievini Hopp BioTech holding GmbH & Co. KG
 dievini Hopp BioTech holding GmbH & Co. KG Investment ManagersFinance dievini Hopp BioTech holding GmbH & Co. KG operates as a private investment and consulting firm. It invests in companies related to the life and health sciences. It focuses with companies that diagnoses and provides therapy in the fields of oncology, neurology, infectious diseases, cell therapy and drug delivery systems. The company is headquartered in Walldorf, Germany. | Investment Managers | Private Equity Investor Founder Chief Executive Officer | |
| IMMATICS N.V. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Beijing Yuanda Huachuang Investment Co., Ltd.
 Beijing Yuanda Huachuang Investment Co., Ltd. Financial ConglomeratesFinance Beijing Yuanda Huachuang Investment Co., Ltd. was founded in 2003 and provides investment services. The company is based in Beijing, China. | Financial Conglomerates | Director/Board Member Director/Board Member Director/Board Member | |
Apogenix AG
 Apogenix AG BiotechnologyHealth Technology Apogenix AG develops immuno-oncology therapeutics for the treatment of cancer and malignant diseases. It offers protein-based therapeutics, including APG101, a human soluble fusion protein combining the extracellular domain of the CD95-receptor and the Fc part blocking CD95L-mediated signaling pathways; and IL-4 blocker that prevents over expression of anti-apoptotic proteins cells. The firm offers its drugs for malignant and inflammatory diseases. The company was founded by Peter Heinrich Krammer and Henning Walczak in 2005 and is headquartered in Heidelberg, Germany. | Biotechnology | Chairman Director/Board Member | |
| University of Mannheim | College/University | Doctorate Degree Undergraduate Degree | |
Hangzhou Jiuyuan Gene Engineering Co. Ltd.
 Hangzhou Jiuyuan Gene Engineering Co. Ltd. Pharmaceuticals: MajorHealth Technology Hangzhou Jiuyuan Gene Engineering Co. Ltd. operates as a biopharmaceutical company. It specializes in R&D, manufacturing and commercialization of biopharmaceutical products and medical devices. Hangzhou Jiuyuan therapeutic includes orthopedics, metabolic diseases, oncology, and hematology services. The company was founded on December 31, 1993 and is headquartered in Hangzhou, China. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Immatics US, Inc.
 Immatics US, Inc. BiotechnologyHealth Technology Immatics US, Inc. develops adoptive cell therapies (ACT) for the treatment of cancer. The company’s ACT therapies are intended to use human T-cells that have been multiplied outside the body before being infused into a cancer patient. It also offers XPRESIDENT, a target discovery engine that enables users to identify, quantify, and prioritize tumor-associated peptides that are recognized by T-cells. The company was founded by Harpreet Singh-Jasuja, Toni Weinschenk, Niels Emmerich, Hans-George Rammensee, Steffen Walter, Peter Brossart and Hansjorg Schild in June 2015 and is headquartered in Houston, TX. | Biotechnology | Director/Board Member Director/Board Member | |
Heidelberg Pharma Research GmbH
 Heidelberg Pharma Research GmbH Miscellaneous Commercial ServicesCommercial Services Part of Heidelberg Pharma AG, Heidelberg Pharma Research GmbH is a German company that engages in researching biotechnology. The company is based in Ladenburg, Germany. The company was founded in 2011. Andreas Pahl has been the CEO of the company since 2012. | Miscellaneous Commercial Services | Chief Executive Officer Chief Executive Officer | |
| CUREVAC N.V. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH Pharmaceuticals: MajorHealth Technology Immatics Biotechnologies GmbH operates as a biopharmaceutical company that develops anti-cancer immunotherapy products. The firm specializes in the discovery and development of immunotherapy products against cancer. It develops IMA901, a combination of multiple tumor-associated peptides (TUMAPs) for the treatment of renal cell carcinoma. The company was founded by Harpreet Singh, Toni Weinschenk, Niels Emmerich, Hans Georg Rammensee, Hansjörg Schild, and Peter Brossart in 2000 and is headquartered in Tübingen, Germany. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SINCLAIR PHARMA PLC | Medical Specialties | Chairman Director/Board Member | |
Novaliq GmbH
 Novaliq GmbH Medical SpecialtiesHealth Technology Novaliq GmbH develops and markets drug delivery systems. The firm specializes in the development of novel pharmaceutical formulations based on semifluorinated alkanes . It product pipeline encompasses the NovaTears, CyckAol, and I-Let Protect technologies. The company was founded in 2004 and is headquartered in Heidelberg, Germany. | Medical Specialties | Chairman Director/Board Member | |
J.F. Müller & Sohn AG
 J.F. Müller & Sohn AG Forest ProductsNon-Energy Minerals J.F. Müller & Sohn AG manufactures hardwood veneer, softwood veneer, and plywood. The company was founded by Friedrich Jacob Müller in 1795 and is headquartered in Hamburg, Germany. | Forest Products | Chairman Chairman | |
febit holding GmbH
 febit holding GmbH Medical/Nursing ServicesHealth Services febit holding GmbH engages in the design and development of technologies used for DNA analysis. It specializes in technologies with applications in genomic research, RNA expression profiling, and other diagnostic and molecular biology fields. The company was founded by Markus Beier, Ramon Gueimil, Peer F. Staehler, Matthias Scheffler, and Cord F. Stähler in 2005 and is headquartered in Heidelberg, Germany. | Medical/Nursing Services | Director/Board Member Chairman | |
LTS LOHMANN Therapie-Systeme AG
 LTS LOHMANN Therapie-Systeme AG Pharmaceuticals: MajorHealth Technology LTS LOHMANN Therapie-Systeme AG manufactures transdermal therapeutic systems and oral thin films. The firm's product range encompasses oral active ingredient films, nicotine patches, and pharmaceutical drugs in dosage forms. Its service areas cover clinical trials, laboratory testing, and research and development projects. The company was founded in 1984 and is headquartered in Andernach, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal Chairman | |
Peking University
 Peking University Other Consumer ServicesConsumer Services Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China. | College/University | Undergraduate Degree Doctorate Degree | |
| Febit, Inc. | Director/Board Member Chairman | ||
China Grand Enterprises, Inc. /Yuanda/
 China Grand Enterprises, Inc. /Yuanda/ Wholesale DistributorsDistribution Services China Grand Enterprises, Inc. distributes construction materials and develops and manages real estate properties. The company is based in Beijing, China. | Wholesale Distributors | Director/Board Member Director of Finance/CFO | |
| GRAND PHARMACEUTICAL GROUP LIMITED | Pharmaceuticals: Major | Chairman Director/Board Member | |
| 2INVEST AG | Financial Conglomerates | Director/Board Member Director/Board Member | |
| Humboldt-Universität zu Berlin | College/University | Undergraduate Degree | |
| Technical University of Berlin | College/University | Corporate Officer/Principal | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Corporate Officer/Principal | |
| Eberhard Karls Universität Tübingen | College/University | Doctorate Degree | |
Covagen AG
 Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland. | Biotechnology | Corporate Officer/Principal | |
| WESTERN SECURITIES CO.,LTD. | Investment Banks/Brokers | Director/Board Member | |
Emergence Therapeutics AG
 Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | Pharmaceuticals: Major | Director/Board Member | |
BIOPRO Baden-Württemberg GmbH
 BIOPRO Baden-Württemberg GmbH Miscellaneous Commercial ServicesCommercial Services BIOPRO Baden-Württemberg GmbH provides business support services to research institutions. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
BIO Deutschland
 BIO Deutschland Miscellaneous Commercial ServicesCommercial Services BIO Deutschland is a business association for the biotechnology industry. The private company is based in Berlin, Germany. The German company was founded by Peter Heinrich, Horst Domdey. Viola Bronsema has been the CEO of the company since 2006. | Miscellaneous Commercial Services | Director of Finance/CFO | |
Knoll AG
 Knoll AG Pharmaceuticals: MajorHealth Technology Part of BASF SE, Knoll AG develops pharmaceuticals. The company is based in Haren, Germany. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| BASF SE | Electrical Products | Corporate Officer/Principal | |
| EBEWE Arzneimittel GmbH | Chief Executive Officer | ||
Esteve Huayi Pharmaceutical Co., Ltd.
 Esteve Huayi Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Esteve Huayi Pharmaceutical Co., Ltd. develops, manufactures and commercializes active pharmaceutical ingredients. It also provides opportunities for custom synthesis and toll manufacture projects. The company was founded in 2005 and is headquartered in Shaoxing, China. | Pharmaceuticals: Major | Chairman | |
| HANGZHOU GREATSTAR INDUSTRIAL CO., LTD | Tools & Hardware | Director/Board Member | |
| Friedrich-Alexander University of Erlangen-Nuremberg | College/University | Corporate Officer/Principal | |
| MOLOGEN AG | Miscellaneous Commercial Services | Director of Finance/CFO | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistics
International
| Germany | 32 |
| China | 10 |
| Switzerland | 4 |
| United States | 4 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 24 |
| Commercial Services | 8 |
| Consumer Services | 7 |
| Finance | 6 |
| Technology Services | 2 |
Operational
| Director/Board Member | 91 |
| Chairman | 41 |
| Chief Executive Officer | 31 |
| Corporate Officer/Principal | 28 |
| Doctorate Degree | 11 |
Most connected contacts
| Insiders | |
|---|---|
| Christof Hettich | 40 |
| Friedrich von Bohlen und Halbach | 36 |
| Mathias Hothum | 19 |
| Birgit Kudlek | 11 |
| Jan Schmidt-Brand | 9 |
| Andreas Pahl | 9 |
| Walter Miller | 8 |
| Georg F. Baur | 8 |
| Cheng Wei Liu | 7 |
| Zhan Qi Niu | 6 |
| Wei Kang | 5 |
| Mathias Locher | 5 |
| Xin Hua Bai | 4 |
| Bang Liang Li | 4 |
| Lan Yang | 3 |
- Stock Market
- Insiders
- Dong Zhou Liu
- Company connections
